DADC
CMD

D.A. Davidson & Co’s Cantel Medical Corporation CMD Stock Holding History

D.A. Davidson & Co’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,507
Closed -$200K – 1225
2021
Q1 		$200K Buy
+2,507
New +$196K ﹤0.01% 1096
2019
Q1 		– Sell
-2,818
Closed -$210K – 1190
2018
Q4 		$210K Sell
2,818
-718
-20% -$59.3K ﹤0.01% 967
2018
Q3 		$326K Buy
3,536
+489
+16% +$46.6K 0.01% 876
2018
Q2 		$300K Buy
3,047
+311
+11% +$34.8K 0.01% 875
2018
Q1 		$305K Buy
+2,736
New +$307K 0.01% 864
2015
Q2 		– Sell
-1,411
Closed -$67K – 2321
2015
Q1 		$67K Sell
1,411
-75
-5% -$3.32K ﹤0.01% 1304
2014
Q4 		$64K Sell
1,486
-18
-1% -$735 ﹤0.01% 1337
2014
Q3 		$51K Sell
1,504
-44
-3% -$1.55K ﹤0.01% 1404
2014
Q2 		$56K Buy
+1,548
New +$52.5K ﹤0.01% 1376

D.A. Davidson & Co's CMD Position: Q2 2021 in Review

D.A. Davidson & Co sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 2,507 shares — an estimated $200K sold.

D.A. Davidson & Co first reported a position in CMD in Q2 2014 and held it in 9 quarters. The position peaked at $326K in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • D.A. Davidson & Co reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,507 Cantel Medical Corporation shares in Q2 2021, an estimated $200K.
  • D.A. Davidson & Co first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 9 quarters.
  • D.A. Davidson & Co's Cantel Medical Corporation position peaked at $326K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on D.A. Davidson & Co's 13F filing for Q2 2021, filed 10 Aug 2021.